These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36997873)

  • 41. Effectiveness of non-pharmaceutical interventions for COVID-19 in USA.
    Liu Y; Wang W; Wong WK; Zhu W
    Sci Rep; 2024 Sep; 14(1):21387. PubMed ID: 39271786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam.
    Nation ML; Manna S; Tran HP; Nguyen CD; Vy LTT; Uyen DY; Phuong TL; Dai VTT; Ortika BD; Wee-Hee AC; Beissbarth J; Hinds J; Bright K; Smith-Vaughan H; Nguyen TV; Mulholland K; Temple B; Satzke C
    Microbiol Spectr; 2023 Feb; 11(1):e0361522. PubMed ID: 36645282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
    Laniece Delaunay C; Mazagatos C; Martínez-Baz I; Túri G; Goerlitz L; Domegan L; Meijer A; Rodrigues AP; Sève N; Ilic M; Latorre-Margalef N; Lazar M; Maurel M; Melo A; Andreu Ivorra B; Casado I; Horváth JK; Buda S; Bennett C; de Lange M; Guiomar R; Enouf V; Mlinaric I; Samuelsson Hagey T; Dinu S; Rumayor M; Castilla J; Oroszi B; Dürrwald R; O'Donnell J; Hooiveld M; Gomez V; Falchi A; Kurecic Filipovic S; Dillner L; Popescu R; Bacci S; Kaczmarek M; Kissling E;
    JAMA Netw Open; 2024 Jul; 7(7):e2419258. PubMed ID: 38949812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of non-pharmaceutical interventions on COVID-19 incidence and deaths: cross-national natural experiment in 32 European countries.
    Costa D; Rohleder S; Bozorgmehr K
    BMC Public Health; 2024 Aug; 24(1):2341. PubMed ID: 39198794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa.
    Mabuka T; Ncube N; Ross M; Silaji A; Macharia W; Ndemera T; Lemeke T
    BMC Public Health; 2023 Aug; 23(1):1492. PubMed ID: 37542267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the impact of COVID-19 variants and vaccination on the time-varying reproduction number: statistical methods.
    Jang G; Kim J; Lee Y; Son C; Ko KT; Lee H
    Front Public Health; 2024; 12():1353441. PubMed ID: 39022412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening and vaccination against COVID-19 to minimise school closure: a modelling study.
    Colosi E; Bassignana G; Contreras DA; Poirier C; Boëlle PY; Cauchemez S; Yazdanpanah Y; Lina B; Fontanet A; Barrat A; Colizza V
    Lancet Infect Dis; 2022 Jul; 22(7):977-989. PubMed ID: 35378075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study.
    Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN
    Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 case doubling time associated with non-pharmaceutical interventions and vaccination: A global experience.
    Liang LL; Kao CT; Ho HJ; Wu CY
    J Glob Health; 2021; 11():05021. PubMed ID: 34552726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the effectiveness of non-pharmaceutical interventions on influenza during the Coronavirus disease 2019 pandemic by time-series forecasting.
    Kim HK; Min KD; Cho SI
    BMC Infect Dis; 2023 Oct; 23(1):717. PubMed ID: 37875817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using outbreak data to estimate the dynamic COVID-19 landscape in Eastern Africa.
    Wamalwa M; Tonnang HEZ
    BMC Infect Dis; 2022 Jun; 22(1):531. PubMed ID: 35681129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of vaccination and non-pharmaceutical interventions and their lag times on the COVID-19 pandemic: Comparison of eight countries.
    Li H; Wang L; Zhang M; Lu Y; Wang W
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010101. PubMed ID: 35025865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021.
    García-García D; Herranz-Hernández R; Rojas-Benedicto A; León-Gómez I; Larrauri A; Peñuelas M; Guerrero-Vadillo M; Ramis R; Gómez-Barroso D
    Euro Surveill; 2022 May; 27(19):. PubMed ID: 35551707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    Schneider KA; Tsoungui Obama HCJ; Adil Mahmoud Yousif N
    PLoS One; 2023; 18(1):e0277505. PubMed ID: 36662784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
    Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing.
    Howerton E; Ferrari MJ; Bjørnstad ON; Bogich TL; Borchering RK; Jewell CP; Nichols JD; Probert WJM; Runge MC; Tildesley MJ; Viboud C; Shea K
    PLoS Comput Biol; 2021 Oct; 17(10):e1009518. PubMed ID: 34710096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transmission of SARS-CoV-2 during indoor clubbing events: A clustered randomized, controlled, multicentre trial protocol.
    Goupil de Bouillé J; Luong Nguyen LB; Crépey P; Garlantezec R; Doré V; Dumas A; Ben Mechlia M; Tattevin P; Gaudart J; Spire B; Lert F; Yazdanpanah Y; Delaugerre C; Noret M; Zeggagh J
    Front Public Health; 2022; 10():981213. PubMed ID: 36438274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling.
    Rowan NJ; Moral RA
    Sci Total Environ; 2021 Jun; 772():145530. PubMed ID: 33581526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland.
    Lemaitre JC; Perez-Saez J; Azman AS; Rinaldo A; Fellay J
    Swiss Med Wkly; 2020 May; 150():w20295. PubMed ID: 32472939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.